ES2187769T3 - Lactitol directamente comprensible y metodo de fabricacion del mismo. - Google Patents

Lactitol directamente comprensible y metodo de fabricacion del mismo.

Info

Publication number
ES2187769T3
ES2187769T3 ES97919075T ES97919075T ES2187769T3 ES 2187769 T3 ES2187769 T3 ES 2187769T3 ES 97919075 T ES97919075 T ES 97919075T ES 97919075 T ES97919075 T ES 97919075T ES 2187769 T3 ES2187769 T3 ES 2187769T3
Authority
ES
Spain
Prior art keywords
lactitol
granulates
physiologically acceptable
directly compressible
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919075T
Other languages
English (en)
Other versions
ES2187769T5 (es
Inventor
Julita Pearson
Philip Olinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco Sweeteners Oy
Original Assignee
Danisco Sweeteners Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24875641&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2187769(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Danisco Sweeteners Oy filed Critical Danisco Sweeteners Oy
Application granted granted Critical
Publication of ES2187769T3 publication Critical patent/ES2187769T3/es
Publication of ES2187769T5 publication Critical patent/ES2187769T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analogue/Digital Conversion (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNOS GRANULADOS DE LACTITOL DIRECTAMENTE COMPRESIBLES Y A UNOS COMPRIMIDOS DE LACTITOL FABRICADOS A PARTIR DE ESTOS GRANULADOS. LOS GRANULADOS CONTIENEN LACTITOLES Y UN LIGANTE NO CARIOGENO FISIOLOGICAMENTE ACEPTABLE, QUE PUEDE ESTAR CONSTITUIDO POR UN ALCOHOL DE AZUCAR NO CARIOGENO, UN AZUCAR REDUCTOR POLIMERIZADO, UNA CARBOXIMETILOCELULOSA ALCALINA, UN HIDROLIZADO DE ALMIDON HIDROGENADO, UNA HIDROXIPROPILCELULOSA, UN DERIVADO DE CELULOSA FISIOLOGICAMENTE ACEPTABLE, POLIVINILPIRROLIDONA, GOMA ARABIGA U OTRA GOMA FISIOLOGICAMENTE ACEPTABLE. EL LIGANTE PREFERIDO ES EL LACTITOL. ESTA INVENCION SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA OBTENCION DE LOS GRANULADOS DE LACTITOL DIRECTAMENTE COMPRESIBLES Y SE PUEDEN UTILIZAR EN EL PRENSADO DE COMPRIMIDOS. LOS COMPRIMIDOS OBTENIDOS DE ESTA MANERA TIENEN UNA DUREZA ELEVADA Y UNA FRIABILIDAD BAJA. SON NO CARIOGENOS Y POSEEN EL PERFIL DE SABOR Y LAS PROPIEDADES METABOLICAS DEL LACTITOL.
ES97919075T 1996-09-19 1997-09-16 Lactitol directamente compresible y metodo de fabricacion del mismo. Expired - Lifetime ES2187769T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/715,825 US5846568A (en) 1996-09-19 1996-09-19 Directly compressible lactitol and method
US715825 1996-09-19

Publications (2)

Publication Number Publication Date
ES2187769T3 true ES2187769T3 (es) 2003-06-16
ES2187769T5 ES2187769T5 (es) 2006-08-16

Family

ID=24875641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919075T Expired - Lifetime ES2187769T5 (es) 1996-09-19 1997-09-16 Lactitol directamente compresible y metodo de fabricacion del mismo.

Country Status (12)

Country Link
US (1) US5846568A (es)
EP (1) EP0938301B2 (es)
JP (1) JP2001502667A (es)
KR (1) KR20000036234A (es)
AT (1) ATE229797T1 (es)
AU (1) AU729040B2 (es)
CA (1) CA2263495A1 (es)
DE (1) DE69718046T3 (es)
ES (1) ES2187769T5 (es)
PL (1) PL332461A1 (es)
RU (1) RU2187999C2 (es)
WO (1) WO1998011878A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107732B (fi) 1998-03-18 2001-09-28 Xyrofin Oy Laktitolin kiteyttäminen, kiteinen laktitolituote ja sen käyttö
NL1009350C2 (nl) * 1998-06-09 1999-12-10 Sara Lee De Nv Zoetstoftablet.
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6384020B1 (en) * 1999-07-14 2002-05-07 Shire Laboratories, Inc. Rapid immediate release oral dosage form
DE19943491B4 (de) * 1999-09-10 2010-04-01 Südzucker AG Mannheim/Ochsenfurt Verbesserte Komprimate
US6872414B1 (en) 1999-09-20 2005-03-29 Xyrofin Oy Anhydrous lactitol crystals, a product containing the same and a process for the preparation thereof as well as use thereof
JP3419729B2 (ja) * 2000-03-16 2003-06-23 株式会社ファンケル 錠剤およびその製造方法
DE60110666T2 (de) 2000-03-17 2006-02-02 Shin-Etsu Chemical Co., Ltd. Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
WO2002100548A2 (en) * 2001-06-13 2002-12-19 Inhale Therapeutic Systems, Inc. Centrifuged rotating drum for treating cohesive powders
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US7682833B2 (en) * 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
CN1686089B (zh) * 2005-05-08 2010-08-18 北京健健康康生物技术有限公司 一种可直接压片的木糖醇颗粒及其制备方法
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
CN103314000B (zh) 2010-11-19 2018-07-27 嘉吉公司 使用具有大孔中性吸附树脂的吸附-脱附色谱用于富集衍生自甜叶菊的糖苷组合物中的新蛇菊苷b和/或新蛇菊苷d的方法
WO2015157262A1 (en) 2014-04-07 2015-10-15 Women & Infants Hospital Of Rhode Island Novel 7-Dehydrocholesterol Derivatives and Methods Using Same
CN104447898B (zh) * 2014-11-06 2017-03-29 山东绿健生物技术有限公司 一种固体乳糖醇及其制备方法与应用
CN105030707B (zh) * 2015-07-10 2020-10-13 南京泽恒医药技术开发有限公司 一种基于改性葡萄糖全粉末直压法制备克霉唑含片的方法
US10806743B1 (en) 2017-05-12 2020-10-20 Braintree Laboratories, Inc. Method of administering lactitol to reduce plasma concentration of lactitol
US20200170291A1 (en) * 2017-05-23 2020-06-04 Particle Dynamics International, Llc Processes for producing lactitol granulates and granulates produced thereby

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536526A (en) * 1988-01-11 1996-07-16 Cultor Ltd. Xylitol-based binding and diluting agent and a process for the production thereof
US5021249A (en) * 1989-11-09 1991-06-04 Warner-Lambert Company Method of making a savory flavor granule and a free flowing savory flavor granule
SU1748822A1 (ru) * 1989-11-21 1992-07-23 Пятигорский фармацевтический институт Способ получени твердой лекарственной формы противовоспалительного средства
GB8928196D0 (en) * 1989-12-13 1990-02-14 Merrell Dow Pharmaceuticals Li Pharmaceutical lozenges
US5204115A (en) * 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
NL9100691A (nl) * 1991-04-19 1992-11-16 Dmv Campina Bv Tabletteerhulpstof.
ATE216577T1 (de) * 1992-01-29 2002-05-15 Takeda Chemical Industries Ltd Schnellösliche tablette und ihre herstellung
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US5651988A (en) * 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives

Also Published As

Publication number Publication date
RU2187999C2 (ru) 2002-08-27
EP0938301B2 (en) 2006-02-22
PL332461A1 (en) 1999-09-13
DE69718046D1 (de) 2003-01-30
WO1998011878A1 (en) 1998-03-26
US5846568A (en) 1998-12-08
DE69718046T2 (de) 2003-05-22
ES2187769T5 (es) 2006-08-16
JP2001502667A (ja) 2001-02-27
DE69718046T3 (de) 2006-10-26
EP0938301B1 (en) 2002-12-18
KR20000036234A (ko) 2000-06-26
ATE229797T1 (de) 2003-01-15
AU729040B2 (en) 2001-01-25
AU4304297A (en) 1998-04-14
EP0938301A1 (en) 1999-09-01
CA2263495A1 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
ES2187769T3 (es) Lactitol directamente comprensible y metodo de fabricacion del mismo.
DE60237826D1 (de) Zusammensetzung enthaltend feine Körner mit verzögerter Freisetzung für in der Mundhöhle schnell zerfallende Tabletten
AR002099A1 (es) Una composicion dentifrica abrasiva de silice de reducida fibrosidad y sabor mejorado y el metodo para obtenerla.
US4802498A (en) Resin-based chewing tobacco
FI932698A0 (fi) Direkt komprimerbar xylitol och foerfarande
EP1602369A3 (en) Bupropion Metabolites and Methods of their Synthesis and Use
AR022358A1 (es) Una composicion de epo, un procedimiento para su obtencion, un preparado farmaceutico que la contiene y un procedimiento para aumentar la actividadespecifica de una composicion de epo
PE20070669A1 (es) Barra alimenticia baja en calorias
AU3805795A (en) Polyol composition obtainable by co-spray-drying
ES2178768T3 (es) Nuevo uso de n-(fosfonometil) glicina y derivados de la misma.
PT1130980E (pt) Bebida para aumento da capacidade de degradacao do alcool
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
AR004790A1 (es) Reduccion del crecimiento del pelo
NO20026124D0 (no) Fremgangsmåte til fremstilling av tremasse fra maisstengel
AR007130A1 (es) Produccion de semillas apomicticas
DK2020864T3 (da) Komprimeret gummi og fremgangsmåde til fremstilling deraf
FI943831A7 (fi) Maaöljypohjainen vahaton purukumi, jolla on parannettu makuaineiden va pautuminen
AR020920A1 (es) Apomixis conferida por la expresion de proteinas que interactuan con serk
WO2008002337A3 (en) Degradable chewing gum
ATE233055T1 (de) Verfahren zur herstellung von zuckerfreien süsswaren
DE59813833D1 (de) Herstellung eines direkt verpressbaren tablettierhilfsstoffes
AR032990A1 (es) Mutantes termoestables de enzimas para la biosintesis de almidon
ES2422423T3 (es) Usos cosméticos y farmacéuticos de un extracto de las semillas de Buchholzia coriacea
BRPI0402497A (pt) Métodos para produzir embriões somáticos conìferos maduros, e embriões somáticos de pinheiro maduros
PE20030596A1 (es) Gomas de mascar y proceso de fabricacion de las mismas